TheEdgeResearch
Home / Stocks / PYPY

YieldMax PYPL Option Income Strategy ETF (PYPY)

AMEX Financial Services Asset Management
$30.55 ▲ +0.23%
Market Cap
$25.6M
Sector
Financial Services
Industry
Asset Management
Beta
0.60
52-Wk Range
24.15-59.135
CEO
Dustin Shindo
Country
US
Currency
USD

YieldMax PYPL Option Income Strategy ETF operates in the Asset Management industry of the Financial Services sector, headquartered in Los Angeles, CA, US. The stock last traded at $30.55, up 0.23% on the session, giving a market capitalisation of $25.6M. Its beta of 0.60 implies it has historically moved less than the broad market.

Company profile
Exchange
New York Stock Exchange Arca
Employees
IPO date
2023-09-26
Headquarters
Los Angeles, CA, US
About YieldMax PYPL Option Income Strategy ETF

PYPY aims to generate monthly income while providing exposure to the price returns of Paypal stock (PYPL), subject to a cap on potential gains. The fund utilizes a synthetic covered call strategy via standardized exchange-traded and FLEX options, which consists of three elements: i) synthetic long exposure, ii) covered call writing, and iii) US Treasurys for collateral. The synthetic long exposure seeks to replicate the price movements of PYPL by purchasing and selling at-the-money calls and puts that have one- to six-month terms. To generate income, the fund writes call options with an expiration of one month or less and a strike price of approximately 0%-15% above PYPL's current share price. This limits participation in potential gains if PYPL shares increase in value. The short put positions fully expose investors to the downside of the stock. Note: the fund does not invest directly in PYPL stocks. Thus, investors are not entitled to any PYPL dividends.

Comparable companies

YieldMax PYPL Option Income Strategy ETF is most often compared with the following Financial Services names:

ABNYDISODSCFFARFXISVLJPMONBFCSNTHWBIYXOMO
More research on PYPY
PYPY technical analysis PYPY TheEdge Score Compare against peers
Open full interactive analysis & DCF →